Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

A woman and her daughter had thallium poisoning from a herbal drink and rodenticide, causing hair loss and other symptoms.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Targeting specific cell interactions may help treat skin fibrosis.

Individualized homeopathic treatment can effectively treat alopecia areata.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Antibiotics often cause skin reactions, making them a major health concern.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Fumaric acid esters, especially dimethylfumarate, improve psoriasis treatment.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

PRP treatment helps hair growth and reduces hair loss in women, but more research needed.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The peptide GHK-Cu helps heal and remodel tissue, improves skin and hair health, and has potential for treating age-related inflammatory diseases.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Some systemic treatments work for nail psoriasis but can have serious side effects.

Some medications can cause acne, and stopping these drugs is the main treatment.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Skin treatment can lower life quality for patients with skin conditions.

Many adults in Porto have acne, but few know or treat it.